Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Yip

Showing results (111-120 of 213) with videos related to

Pageof 22
Sort By:
Neuro-Oncology|May 10, 2021
Loss of H3K27me3 in meningiomasFarshad Nassiri, Justin Z Wang, Olivia Singh, et al.
Cold Spring Harbor Molecular Case Studies|February 14, 2018
Molecular characterization of <i>ERBB2</i>-amplified colorectal cancer identifies potential mechanisms of resistance to targeted therapies: a report of two instructive casesDaniel R Owen, Hui-Li Wong, Melika Bonakdar, et al.
Cold Spring Harbor Molecular Case Studies|September 8, 2017
Detection and genomic characterization of a mammary-like adenocarcinomaJasleen K Grewal, Peter Eirew, Martin Jones, et al.
Current Oncology (Toronto, Ont.)|April 21, 2022
The Clinically Actionable Molecular Profile of Early versus Late-Stage Non-Small Cell Lung Cancer, an Individual Age and Sex Propensity-Matched Pair AnalysisAnna L McGuire, Melissa K McConechy, Barb L Melosky, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 14, 2022
Recommendations for the implementation of genetic testing for metastatic prostate cancer patients in CanadaShamini Selvarajah, Kasmintan A Schrader, Michael P Kolinsky, et al.
Stem Cells (Dayton, Ohio)|March 15, 2012
Polo-like kinase 1 inhibition kills glioblastoma multiforme brain tumor cells in part through loss of SOX2 and delays tumor progression in miceCathy Lee, Abbas Fotovati, Joanna Triscott, et al.
Journal of Neuropathology and Experimental Neurology|May 29, 2026
Histopathological and molecular heterogeneity of dysembryoplastic neuroepithelial tumorsYuxiu Wang, Sarra Belakhoua, Yiying Yang, et al.
Clinical Case Reports|March 26, 2021
NTRK2 Fusion driven pediatric glioblastoma: Identification of oncogenic Drivers via integrative Genome and transcriptome profilingHeidi M Britton, Adrian B Levine, Yaoqing Shen, et al.
Annals of Neurology|June 22, 2012
DNA hypermethylation and 1p Loss silence NHE-1 in oligodendrogliomaMichael D Blough, Mohammad Al-Najjar, Charles Chesnelong, et al.
BMC Cancer|December 20, 2014
Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomasAlicia A Tone, Melissa K McConechy, Winnie Yang, et al.
Pageof 22

Showing results (111-120 of 213) with videos related to

Sort By:
Pageof 22
Neuro-Oncology|May 10, 2021
Loss of H3K27me3 in meningiomasFarshad Nassiri, Justin Z Wang, Olivia Singh, et al.
Cold Spring Harbor Molecular Case Studies|February 14, 2018
Molecular characterization of <i>ERBB2</i>-amplified colorectal cancer identifies potential mechanisms of resistance to targeted therapies: a report of two instructive casesDaniel R Owen, Hui-Li Wong, Melika Bonakdar, et al.
Cold Spring Harbor Molecular Case Studies|September 8, 2017
Detection and genomic characterization of a mammary-like adenocarcinomaJasleen K Grewal, Peter Eirew, Martin Jones, et al.
Current Oncology (Toronto, Ont.)|April 21, 2022
The Clinically Actionable Molecular Profile of Early versus Late-Stage Non-Small Cell Lung Cancer, an Individual Age and Sex Propensity-Matched Pair AnalysisAnna L McGuire, Melissa K McConechy, Barb L Melosky, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 14, 2022
Recommendations for the implementation of genetic testing for metastatic prostate cancer patients in CanadaShamini Selvarajah, Kasmintan A Schrader, Michael P Kolinsky, et al.
Stem Cells (Dayton, Ohio)|March 15, 2012
Polo-like kinase 1 inhibition kills glioblastoma multiforme brain tumor cells in part through loss of SOX2 and delays tumor progression in miceCathy Lee, Abbas Fotovati, Joanna Triscott, et al.
Journal of Neuropathology and Experimental Neurology|May 29, 2026
Histopathological and molecular heterogeneity of dysembryoplastic neuroepithelial tumorsYuxiu Wang, Sarra Belakhoua, Yiying Yang, et al.
Clinical Case Reports|March 26, 2021
NTRK2 Fusion driven pediatric glioblastoma: Identification of oncogenic Drivers via integrative Genome and transcriptome profilingHeidi M Britton, Adrian B Levine, Yaoqing Shen, et al.
Annals of Neurology|June 22, 2012
DNA hypermethylation and 1p Loss silence NHE-1 in oligodendrogliomaMichael D Blough, Mohammad Al-Najjar, Charles Chesnelong, et al.
BMC Cancer|December 20, 2014
Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomasAlicia A Tone, Melissa K McConechy, Winnie Yang, et al.
Pageof 22